Scientists probe rabies Shot's hidden immune secrets

NCT ID NCT07399951

Summary

This study aims to understand how the body's immune system responds to the standard rabies vaccine when it is given alongside an extra dose of rabies-fighting antibodies (RIG) at different times. Researchers will compare three groups of 30 healthy adults: one getting the standard two-shot vaccine, one getting the vaccine with antibodies on day 0, and one getting the vaccine with antibodies on day 28. The goal is to gather knowledge about how these combinations affect long-term immunity, not to test a new cure or treatment.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEALTHY PARTICIPANTS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Washington University School of Medicine Infectious Disease Clinical Trials Unit.

    St Louis, Missouri, 63110, United States

Conditions

Explore the condition pages connected to this study.